Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2011-04-14 Proxy Solicitation & In…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
CO-#13922882-v1-THR_JAV_2011_-_volmacht_BAV_NL.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled 'VOLMACHT' (Proxy/Power of Attorney) in Dutch. It explicitly details the authorization given by a shareholder ('volmachtgever') to a representative ('lasthebber') to attend and vote at an 'buitengewone algemene vergadering der aandeelhouders' (Extraordinary General Meeting of Shareholders) of the company 'ThromboGenics'. The agenda items concern the approval of a new warrant plan and capital increase. This document is a formal instrument used to grant voting rights for a general meeting, which aligns directly with the purpose of a Proxy Solicitation & Information Statement, although it is specifically the proxy form itself. Given the options, 'PSI' (Proxy Solicitation & Information Statement) is the most appropriate classification for materials related to soliciting and managing shareholder votes for a meeting, even if this specific text is the proxy form rather than the full information statement. It is not the AGM presentation (AGM-R) or the results (DVA), but the mechanism for voting at the meeting.
2011-04-14 Dutch
CO-#13587475-v8-THR_JAV_2011_-_warrantenplan_2011.pdf
Capital/Financing Update Classification · 95% confidence The document is titled "WARRANTENPLAN 2011" (Warrant Plan 2011) and contains detailed definitions and conditions related to the granting, terms, and exercise of warrants (stock options/rights) to employees and consultants of ThromboGenics NV. This type of document outlines a specific employee incentive scheme involving capital structure elements (warrants leading to shares). This fits best under 'Capital/Financing Update' (CAP) as it directly relates to the issuance of rights tied to the company's capital structure, although it is a plan document rather than a transactional announcement. However, given the specific definitions, it is a plan governing future capital changes. Since there is no specific code for 'Stock Option Plan' or 'Incentive Plan', the closest fit among the provided options that deals with capital structure changes and issuance rights is 'CAP' (Capital/Financing Update). It is not an earnings release (ER), annual report (10-K), or a simple dividend notice (DIV). It is a formal plan document, not a short announcement (RPA/RNS).
2011-04-14 Dutch
CO-#13938226-v1-THR_statutaire_jaarrekening_31_12_2010.PDF
Audit Report / Information Classification · 98% confidence The document is a formal Belgian 'Jaarrekening' (Annual Accounts) for the company ThromboGenics. It contains detailed balance sheets, lists of directors, and statutory financial disclosures required by Belgian law. While it is part of the annual reporting process, it is a standalone financial statement filing rather than a narrative 10-K report. Given the specific structure of Belgian annual accounts, it falls under the category of Audit Report / Information (AR) as it represents the official financial filing. FY 2010
2011-04-14 Dutch
THR_JAV_2011-Jaarverslag Raad van Bestuur over statutaire JR.pdf
Annual Report Classification · 100% confidence The document is titled 'Jaarverslag van de Raad van Bestuur over de statutaire jaarrekening' (Annual Report of the Board of Directors on the statutory annual accounts) for the fiscal year ending December 31, 2010. It contains detailed financial performance data, including profit/loss statements, revenue breakdowns, capital increases, risk management, and governance disclosures (Article 523). As it provides a comprehensive review of the company's annual activities and financial status, it is classified as an Annual Report (10-K). FY 2010
2011-04-14 Dutch
THR_JAV_2011-Verslag van de comm over JR 2010.pdf
Audit Report / Information Classification · 100% confidence The document is a formal 'Verslag van de commissaris' (Auditor's Report) addressed to the shareholders of ThromboGenics NV regarding the annual accounts for the fiscal year ending December 31, 2010. It contains the auditor's opinion on the financial statements, compliance with Belgian accounting standards, and additional statutory disclosures. This fits the definition of a standalone audit report (AR) rather than a full annual report (10-K) or a management report (MDA). FY 2010
2011-04-14 Dutch
THR_JAV_2011-Geconsolideerde jaarrekening afgesloten per 31.12.2010_NL.pdf
Annual Report Classification · 100% confidence The document is titled 'Jaarverslag 2010', which translates to 'Annual Report 2010'. It contains detailed sections typical of an annual report, including consolidated balance sheets, profit and loss accounts, corporate governance, risk factors, and auditor's statements. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes comprehensive financial data, management discussion, and governance information, consistent with an official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2010
2011-04-14 Dutch

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.